Core Viewpoint - The article highlights the significant stock performance of Pop Mart, which surged over 9% due to share buybacks and positive analyst ratings from Morgan Stanley, while also noting the approval of a new drug clinical trial by Heng Rui Pharmaceutical [5][12]. Group 1: Pop Mart Stock Performance - Pop Mart experienced a notable increase of 9.07%, closing at HKD 197.20 per share, with a peak increase of 10.40% during the trading day [6][5]. - The company repurchased 1.4 million shares on January 19, spending HKD 251 million, which contributed to the stock's upward momentum [9][11]. - Morgan Stanley's report projected Pop Mart's net profit for 2025 to be RMB 12.6 billion, indicating strong financial resources for shareholder returns [11]. Group 2: Heng Rui Pharmaceutical Developments - Heng Rui Pharmaceutical received approval for the clinical trial of its drug HRS-2141, aimed at treating type 2 diabetes, marking a significant step in its drug development pipeline [13][17]. - The company has invested approximately RMB 5.4 million in the development of HRS-2141, which is currently in the early stages of clinical trials [17]. - Despite the positive news regarding the drug approval, Heng Rui's stock fell by 4.36% to HKD 73.55 per share on January 20, reflecting market volatility [18].

Core Viewpoint - Haier Smart Home (06690.HK) announced a share buyback plan with a maximum limit of €2 million, excluding additional buyback costs, to be executed at the 2024 annual general meeting scheduled for May 28, 2025 [1] Group 1: Share Buyback Plan - The company plans to repurchase up to 1 million D-shares, representing approximately 0.369% of its current D-share capital [1] - The shares repurchased under the plan will be canceled, thereby reducing the company's capital [1] - The buyback will be conducted through the XETRA® trading system at the Frankfurt Stock Exchange and selected multilateral trading facilities within the EU [1] Group 2: Timeline and Impact - The buyback program is set to commence around January 21, 2026, and will continue until February 13, 2026 [1] - The company believes that this capital reduction will have a positive impact on its capital structure [1]

Core Viewpoint - Haier Smart Home (06690) announced a share buyback plan with a maximum scale of €2 million, aimed at enhancing its capital structure through the repurchase and cancellation of shares [1] Group 1: Share Buyback Plan - The company will repurchase up to 1 million D-shares, representing approximately 0.369% of its current D-share capital [1] - The buyback will be conducted via the XETRA® trading system on the Frankfurt Stock Exchange and selected multilateral trading facilities within the EU [1] - The buyback program is set to commence on or around January 21, 2026, and will continue until February 13, 2026 [1] Group 2: Capital Reduction - The shares repurchased under the plan will be canceled, leading to a reduction in the company's capital [1] - The company believes that this capital reduction will have a positive impact on its capital structure [1]

Group 1 - The core point of the news is that Pop Mart's stock surged over 9% due to a share buyback and positive outlook from Morgan Stanley, while the overall Hong Kong market experienced a decline [1][5][6] - Pop Mart's share price increased by 9.07%, closing at HKD 197.20 per share, with a trading volume of HKD 58.79 billion, ranking fourth among Hang Seng Index constituents [5][6] - The company repurchased 1.4 million shares on January 19 at a total cost of HKD 251 million, with plans to cancel the repurchased shares [5][6] Group 2 - Morgan Stanley's report predicts Pop Mart's net profit for 2025 to be RMB 12.6 billion, with an expected cash reserve of RMB 20 billion by the end of 2025, indicating strong financial resources for shareholder returns [6] - Heng Rui Medicine announced the approval of clinical trials for its new drug HRS-2141, aimed at treating type 2 diabetes, marking a significant step in its drug development pipeline [7][10] - The drug HRS-2141 is a fixed-dose combination formulation, with no similar drugs approved in the domestic and international markets, and the company has invested approximately RMB 5.4 million in its development so far [10][11]

Core Viewpoint - The company announced a share repurchase plan initiated in March 2022, with a total expenditure of 199 million yuan for repurchasing shares for employee stock ownership plans and later changing the purpose to equity incentives [1] Group 1: Share Repurchase and Usage - In March 2022, the company decided to repurchase shares amounting to 150 to 300 million yuan for employee stock ownership plans [1] - As of March 2023, the company had repurchased a total of 18.38 million shares, costing 199 million yuan [1] - The purpose of the repurchased shares was later changed to equity incentives [1] Group 2: Stock Grant and Cancellation - In 2024, the company granted 12.99 million restricted shares to 289 incentive recipients, with 5.39 million shares remaining [1] - In 2025, the board and shareholders agreed to cancel the remaining shares [1] - The cancellation was completed on January 21, 2026, reducing the total share capital from 1.525 billion shares to 1.519 billion shares, without affecting the company's listing status [1]

Group 1 - The core announcement is that Skyworth Group plans to apply for the listing and trading of Skyworth Photovoltaic shares on the Hong Kong Stock Exchange through an introduction method, without a public offering of shares [1] - The board of directors decided on January 4, 2026, to propose the listing of Skyworth Photovoltaic, which includes a distribution of shares to all shareholders, contingent upon meeting certain conditions [1] - The company will also implement a share buyback plan, allowing shareholders to exchange shares for either cash at HKD 4.03 per share or new shares, subject to the fulfillment of specific conditions [1] Group 2 - The company has applied to the Hong Kong Stock Exchange for the resumption of trading of its shares starting from 9:00 AM on January 21, 2026 [1]

Core Viewpoint - Haier Smart Home announced a plan to repurchase shares of its D stock, with a maximum expenditure of up to 2 million euros, excluding related costs, and a maximum quantity of up to 1 million shares, which represents approximately 0.369% of the company's D stock capital and 0.011% of the total share capital [1] Group 1 - The company intends to repurchase D shares, which will subsequently be canceled, leading to a reduction in registered capital [1]

Group 1 - The company announced a share buyback of 2.51 billion HKD for 1.4 million shares, with a buyback price range of 177.7 to 181.2 HKD per share [1] - The buyback is conducted under the authorization approved at the 2025 shareholder meeting, allowing for a maximum repurchase of approximately 134.3 million shares, with about 132.6 million shares remaining for future buybacks [1] - The repurchased shares will be fully canceled, reducing the total issued shares from 1.34294 billion to 1.34154 billion, representing 0.1042% of the shares before the buyback [1] Group 2 - The company's stock price has been in a downward trend since reaching a high of 339.8 HKD in late August 2025, but the buyback announcement led to a significant increase in stock price, rising over 10% during the day and closing at 197.2 HKD, a 9.07% increase [1] - The company has a history of share buybacks, having repurchased 34.3 million shares for 735 million HKD in 2022 and 19.9 million shares for approximately 371 million HKD in 2023, with buyback prices ranging from 16.94 to 20.60 HKD [2] - The company has shown significant revenue growth, with revenues of 4.617 billion, 6.301 billion, and 13.038 billion CNY from 2022 to 2024, representing year-on-year growth rates of 2.82%, 36.46%, and 106.92% respectively [2] Group 3 - In the first half of 2025, the company achieved revenues of 13.876 billion CNY, a year-on-year increase of 204.45%, and a net profit of 4.574 billion CNY, up 396.49% [3]

格隆汇1月20日丨海尔智家(600690.SH)公布，拟通过法兰克福证券交易所的XETRA®交易系统以及欧盟 境内选定的多边交易设施进行回购公司股份，拟回购总金额最高不超过200万欧元，或拟回购最大数量 不超过100万股（约占公司D股股本的0.369%，占公司总股本的0.011%）。回购股份将用于注销D股股 份，减少注册资本，优化资本结构。回购期限为2026年1月21日或前后开始，持续至2026年2月13日。 ...

Group 1 - The company Haier Smart Home (600690) announced a plan to repurchase shares, with a maximum expenditure of up to 2 million euros (excluding related costs) [1] - The repurchase will involve a maximum of 1 million shares, which represents approximately 0.369% of the company's D-share capital and about 0.011% of the total share capital [1] - The repurchased D-shares will be canceled, leading to a reduction in the company's registered capital [1]